The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines

被引:333
作者
Kim, JI
Ho, IC
Grusby, MJ
Glimcher, LH
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1016/S1074-7613(00)80073-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-4 promotes the differentiation of naive CD4(+) T cells into IL-4-producing T helper 2 (Th2) cells. Previous work provided suggestive but not conclusive evidence that the transcription factor c-Maf directed the tissue-specific expression of IL-4. It was not known whether c-Maf controlled the transcription of other Th2 cytokine genes. To elucidate the role of c-Maf in vivo, we examined cytokine production in mice lacking c-Maf (c-maf(-/-)). CD4(+) T cells and NK T cells from c-maf(-/-) mice were markedly deficient in IL-4 production. However, the mice produced normal levels of IL-13 and IgE, and, when differentiated in the presence of exogenous IL-4, c-maf(-/-) T cells produced approximately normal levels of other Th2 cytokines. We conclude that c-Maf has a critical and selective function in IL-4 gene transcription in vivo.
引用
收藏
页码:745 / 751
页数:7
相关论文
共 50 条
[1]   AN INTERLEUKIN-4 (IL-4) MUTANT PROTEIN INHIBITS BOTH IL-4 OR IL-13-INDUCED HUMAN IMMUNOGLOBULIN-G4 (IGG4) AND IGE SYNTHESIS AND B-CELL PROLIFERATION - SUPPORT FOR A COMMON COMPONENT SHARED BY IL-4 AND IL-13 RECEPTORS [J].
AVERSA, G ;
PUNNONEN, J ;
COCKS, BG ;
MALEFYT, RD ;
VEGA, F ;
ZURAWSKI, SM ;
ZURAWSKI, G ;
DEVRIES, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2213-2218
[2]   Differences between IL-4Rα-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses [J].
Barner, M ;
Mohrs, M ;
Brombacher, F ;
Kopf, M .
CURRENT BIOLOGY, 1998, 8 (11) :669-672
[3]   Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1T cells [J].
Bendelac, A ;
Hunziker, RD ;
Lantz, O .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1285-1293
[4]   In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice [J].
Bost, KL ;
Holton, RH ;
Cain, TK ;
Clements, JD .
IMMUNOLOGY, 1996, 87 (04) :633-641
[5]   beta 2-microglobulin-dependent NK1.1(+) T cells are not essential for T helper cell 2 immune responses [J].
Brown, DR ;
Fowell, DJ ;
Corry, DB ;
Wynn, TA ;
Moskowitz, NH ;
Cheever, AW ;
Locksley, RM ;
Reiner, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1295-1304
[6]  
BROWN KD, 1989, J IMMUNOL, V142, P679
[7]  
Chiaramonte MG, 1999, J IMMUNOL, V162, P920
[8]  
Cohn L, 1998, J IMMUNOL, V161, P3813
[9]  
Csonga R, 1998, J IMMUNOL, V160, P273
[10]   INTERLEUKIN-13 IS A B-CELL STIMULATING FACTOR [J].
DEFRANCE, T ;
CARAYON, P ;
BILLIAN, G ;
GUILLEMOT, JC ;
MINTY, A ;
CAPUT, D ;
FERRARA, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :135-143